| # | Title | Journal | Year | Citations |
|---|
| 1 | Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis | JNCI Cancer Spectrum | 2020 | 205 |
| 2 | Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review | JNCI Cancer Spectrum | 2018 | 199 |
| 3 | Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors | JNCI Cancer Spectrum | 2020 | 126 |
| 4 | Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58 | JNCI Cancer Spectrum | 2018 | 115 |
| 5 | An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients | JNCI Cancer Spectrum | 2020 | 114 |
| 6 | Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer | JNCI Cancer Spectrum | 2018 | 110 |
| 7 | Preventable Cancer Burden Associated With Poor Diet in the United States | JNCI Cancer Spectrum | 2019 | 95 |
| 8 | Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information | JNCI Cancer Spectrum | 2023 | 95 |
| 9 | Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift | JNCI Cancer Spectrum | 2023 | 94 |
| 10 | The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management | JNCI Cancer Spectrum | 2018 | 92 |
| 11 | A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus | JNCI Cancer Spectrum | 2021 | 81 |
| 12 | Intentional Weight Loss and Obesity-Related Cancer Risk | JNCI Cancer Spectrum | 2019 | 80 |
| 13 | Cancer Treatment-Related Infertility: A Critical Review of the Evidence | JNCI Cancer Spectrum | 2019 | 75 |
| 14 | Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988–2012 | JNCI Cancer Spectrum | 2019 | 75 |
| 15 | Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers | JNCI Cancer Spectrum | 2020 | 75 |
| 16 | Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability | JNCI Cancer Spectrum | 2018 | 71 |
| 17 | Circulating Tumor Cells in Early Breast Cancer | JNCI Cancer Spectrum | 2019 | 63 |
| 18 | Exposure to Tomographic Scans and Cancer Risks | JNCI Cancer Spectrum | 2020 | 61 |
| 19 | Emerging Cancer Survival Trends, Disparities, and Priorities in Adolescents and Young Adults: A California Cancer Registry-Based Study | JNCI Cancer Spectrum | 2019 | 60 |
| 20 | Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies | JNCI Cancer Spectrum | 2020 | 59 |
| 21 | Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival | JNCI Cancer Spectrum | 2018 | 54 |
| 22 | Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015 | JNCI Cancer Spectrum | 2019 | 53 |
| 23 | A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses | JNCI Cancer Spectrum | 2019 | 52 |
| 24 | Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors | JNCI Cancer Spectrum | 2021 | 52 |
| 25 | 40 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men | JNCI Cancer Spectrum | 2019 | 49 |
| 26 | Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment | JNCI Cancer Spectrum | 2020 | 49 |
| 27 | Race, Socioeconomic Status, and Health-Care Access Disparities in Ovarian Cancer Treatment and Mortality: Systematic Review and Meta-Analysis | JNCI Cancer Spectrum | 2019 | 48 |
| 28 | Area Deprivation Index and Rurality in Relation to Lung Cancer Prevalence and Mortality in a Rural State | JNCI Cancer Spectrum | 2020 | 48 |
| 29 | Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer | JNCI Cancer Spectrum | 2019 | 46 |
| 30 | Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603) | JNCI Cancer Spectrum | 2020 | 46 |
| 31 | Mutation Signatures Including APOBEC in Cancer Cell Lines | JNCI Cancer Spectrum | 2018 | 45 |
| 32 | Human Papillomavirus Vaccination After COVID-19 | JNCI Cancer Spectrum | 2021 | 44 |
| 33 | Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis | JNCI Cancer Spectrum | 2020 | 41 |
| 34 | Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study | JNCI Cancer Spectrum | 2021 | 40 |
| 35 | Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential | JNCI Cancer Spectrum | 2020 | 39 |
| 36 | Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer | JNCI Cancer Spectrum | 2021 | 39 |
| 37 | The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors | JNCI Cancer Spectrum | 2019 | 38 |
| 38 | Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients | JNCI Cancer Spectrum | 2021 | 37 |
| 39 | Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer | JNCI Cancer Spectrum | 2020 | 36 |
| 40 | Cancer in General Responders Participating in World Trade Center Health Programs, 2003–2013 | JNCI Cancer Spectrum | 2020 | 36 |
| 41 | Prometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women | JNCI Cancer Spectrum | 2018 | 35 |
| 42 | Delivery of Financial Navigation Services within National Cancer Institute-Designated Cancer Centers | JNCI Cancer Spectrum | 2021 | 35 |
| 43 | Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma | JNCI Cancer Spectrum | 2019 | 34 |
| 44 | Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials | JNCI Cancer Spectrum | 2020 | 34 |
| 45 | Association of the Insulinemic Potential of Diet and Lifestyle With Risk of Digestive System Cancers in Men and Women | JNCI Cancer Spectrum | 2018 | 33 |
| 46 | Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study | JNCI Cancer Spectrum | 2018 | 33 |
| 47 | Dietary Pattern and Risk of Multiple Myeloma in Two Large Prospective US Cohort Studies | JNCI Cancer Spectrum | 2019 | 33 |
| 48 | Lung Cancer Mortality in the Lung Screening Study Feasibility Trial | JNCI Cancer Spectrum | 2018 | 31 |
| 49 | Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women’s Health Initiative Observational Study | JNCI Cancer Spectrum | 2019 | 30 |
| 50 | Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies | JNCI Cancer Spectrum | 2018 | 29 |
